-

Thermo Fisher Scientific’s PPD Clinical Research Business Earns Honor for Employee Development Driving Customer Success

WILMINGTON, N.C.--(BUSINESS WIRE)--Thermo Fisher Scientific’s PPD clinical research business has been named a winner in Training magazine’s 2022 Training APEX Awards, recognizing its robust enterprise learning programs designed to grow employees’ skills and drive customers’ success.

As part of Thermo Fisher’s commitment to talent development, the PPD clinical research business designs, develops and deploys a wide range of employee learning and performance programs, providing ongoing training and development that engages employees for optimal performance, leverages technology, develops staff and measures outcomes.

“We are honored to win this award for the 11th consecutive year from the highly regarded team at Training magazine,” said Jay Dixon, senior vice president, quality and enterprise learning, clinical research, Thermo Fisher Scientific. “Our learning programs proactively, measurably and efficiently improve performance, readiness and quality across the organization to best serve our customers and help them achieve their clinical research goals.”

Training magazine’s Training APEX Awards were recently rebranded from the Training Top 100. The awards honor each winner’s journey to attain peak performance in employee training and development and organizational success. The awards assessment team evaluated the scope of each organization’s learning program, including budget, reimbursement, infrastructure, evaluation, human resources and metrics.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.

Contacts

Media Contact Information:
Nadine Maeser
Clinical Research, Thermo Fisher Scientific
Phone: 910-558-4779
Email: nadine.maeser@ppd.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Summary
Thermo Fisher Scientific’s PPD clinical research business has been recognized for its robust enterprise learning programs
Release Versions

Contacts

Media Contact Information:
Nadine Maeser
Clinical Research, Thermo Fisher Scientific
Phone: 910-558-4779
Email: nadine.maeser@ppd.com

More News From Thermo Fisher

Nalgene Outdoor Expands Mythical Creatures Collection with Mothman, The Loch Ness Monster and Jackalope

ROCHESTER, N.Y.--(BUSINESS WIRE)--Just in time for Halloween, Nalgene Outdoor is adding a little inspiration to spooky season and trick-or-treat traditions with three new designs in its limited-edition Mythical Creatures collection: Mothman, the Loch Ness Monster and Jackalope. The new designs join aliens, werewolves and Sasquatch, bringing six legendary characters to Nalgene’s iconic 32-ounce bottles just in time for fall traditions. Whether they inspire a last-minute Halloween costume, come a...

Thermo Fisher Scientific Showcases New Solutions and Expanded Capabilities to Accelerate Drug Development at CPHI Milan 2026

MILAN--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, is expanding its drug development, manufacturing, and clinical capabilities to help pharmaceutical and biotechnology companies navigate increasingly complex paths to commercialization, reduce friction, and maintain momentum. The company will showcase these new and expanded capabilities at CPHI Milan 2026, Oct. 6-8. Among the new offerings is OSD Express, a defined solution designed to increase predictability...

Thermo Fisher Scientific Proteomics Technologies Enable Discovery of More Than 2,500 New Biological Associations in PRECISE-SG100K Study

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its strategic collaboration with Precision Health Research, Singapore (PRECISE) and Nanyang Technological University, Singapore (NTU Singapore) has led to the discovery of more than 2,500 previously unreported genetic-protein associations. By combining Thermo Fisher’s complementary proteomics technologies with PRECISE-SG100K's large-scale health and genomic data, researchers...
Back to Newsroom